Sentences with phrase «pharmacogenomic research»

15:00 15:30 Surakameth Mahasirimongkol, Medical Researcher, National Institute of Health, Department of Medical Sciences, Ministry of Public Health and Scientific manager, Pharmacogenomic research project, Thailand Center For Excellence in Life Sciences (TCELS)

deCODE's pharmacogenomic research is particularly vital in the near term because glucocorticoids, which represent one of the most widely - used and powerful treatments for asthma, can also have severe side - effects, particularly in children.

Furthermore, results of this study provide essential directions to future pharmacogenomic research for reduction of ADR - related hospitalizations in Singapore,» said Professor Alexandre Chan, co-senior author of the British Journal of Clinical Pharmacology study.

Overall, the DruGeVar database is expected to contribute towards bridging the gap between pharmacogenomics research findings and clinical practice.

15:30 16:00 Jae Gook Shin, Professor and Head, Department of Pharmacology and Clinical Pharmacology Director, Pharmacogenomics Research Center Inje University College of Medicine and Director, Clinical Trial Center Inje University Busan Paik Hospital, Busan, South Korea

Dr. Relling is part of NIH's Pharmacogenomics Research Network and co-founder of CPIC, the Clinical Pharmacogenetics Implementation Consortium.

Not exact matches

With a potential universe of nearly two and a half million people (including employees and their families), the opportunity for pharmacogenomic and clinical research is immense.

Pharmacogenomics — the study of how genes affect responses to drugs — is becoming more important in drug - development research and clinical trials, with a view toward decreasing side effects and increasing the efficiency and efficacy of drugs in patients with the right genetic profiles.

He has previously served on the faculty of McGill University in Montreal as a Tier I Canada Research Chair and the Salk Institute in San Diego, and has made significant contributions to the field of integrative proteomics and pharmacogenomics through the use of innovative mass spectrometry and biochemical techniques.

And the field of pharmacogenomics, which was new when the research network began in 2000, has matured enough for its scientists to compete effectively with grant applicants in other fields, says Lorsch.

The Genomics and Pharmacogenomics Working Group aims to undertake and coordinate research projects that will facilitate the integration of genomics applications and pharmacogenomics Pharmacogenomics Working Group aims to undertake and coordinate research projects that will facilitate the integration of genomics applications and pharmacogenomics pharmacogenomics into healthcare.

His research interests involve pharmacogenomics for hemoglobinopathies and neuropsychiatric disorders, transcriptional regulation of human fetal globin genes and genotype - phenotype correlation in human genetic disorders.

He is the first Associate Director for Oncology Research in the Institute for Pharmacogenomics and Individualized Therapy.

(2) Treatment research, testing the effectiveness of addiction treatments and their underlying processes, e.g. treatment efficacy, process evaluation, double diagnosis treatmentss, and patient - treatment matching (pharmacogenomics).

In this research article from Pharmacogenomics discover the prevalence of CYP2D6 and CYP2C19 polymorphisms in psychiatric patients and volunteers from Dutch caribbean origin.

Today, the Golden Helix Foundation and the Section of Pharmacogenomics and Pharmacogenetics of International Union of Basic and Clinical Pharmacology (IUPHAR) have entered into a collaborative agreement to foster their cooperation and to advance basic and clinical research in pharmacogenomics, its clinical translation and educational and learPharmacogenomics and Pharmacogenetics of International Union of Basic and Clinical Pharmacology (IUPHAR) have entered into a collaborative agreement to foster their cooperation and to advance basic and clinical research in pharmacogenomics, its clinical translation and educational and learpharmacogenomics, its clinical translation and educational and learning activities.

In furtherance of their mutual interest in improving fundamental and clinical pharmacogenomics and its translation into clinical practice, the two organizations have agreed: (a) cooperate and collaborate on programs and activities of mutual interest, (b) work together to provide education symposia / workshops in developing countries and regions, and (c) foster collaborative research to better understand the genetic basis for ethnic diversity in the response to and adverse effects from medicines.

With its uniquely comprehensive population data, deCODE is turning research on the genetic causes of common diseases into a growing range of products and services — in gene discovery, pharmaceuticals, DNA - based diagnostics, pharmacogenomics, in silico discovery tools, bioinformatics and medical decision support systems.

The Sections aims are, to promote the exchange of pharmacogenetic knowledge by organization of symposia and workshops in the field of pharmacogenetics and genomics, to evaluate the clinical impact of pharmacogenetics, to assist with the development and maintenance of drug - related pharmacogenetic databases and to create a population based biobank to conduct translational research in clinical pharmacogenomics.

Hakonarson H and Stefansson K Role of pharmacogenomics in drug development Drug Development Research 2004 62 (2): 86 - 96

With its uniquely comprehensive population data, deCODE is turning research on the genetic causes of common diseases into a growing pipeline of products and services — in pharmaceuticals, gene and drug discovery, DNA - based diagnostics, pharmacogenomics, bioinformatics, and clinical trials.

The Pathology Shared Resource facilitates project planning, clinical validation and implementation of novel translational technology and research in the fields of molecular diagnostics, molecular therapeutics, pharmacogenomics, quantitative morphologic image analysis and immunohistochemistry (IHC) in a CLIA - certified, CAP - accredited laboratory ensuring optimal clinical quality assurance.